HuGE Literature Finder
Records
1
-
6
Genomic characterization of functional high-risk multiple myeloma patients. Blood cancer journal 2022 2 12 (1): 24. Soekojo Cinnie Yentia, Chung Tae-Hoon, Furqan Muhammad Shaheryar, Chng Wee J |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances 2021 10 6 (2): 637-651. Witte Hanno M, Künstner Axel, Hertel Nadine, Bernd Heinz-Wolfram, Bernard Veronica, Stölting Stephanie, Merz Hartmut, von Bubnoff Nikolas, Busch Hauke, Feller Alfred C, Gebauer Nikl |
Master and servant: LINC00152 - a STAT3-induced long noncoding RNA regulates STAT3 in a positive feedback in human multiple myeloma. BMC medical genomics 2020 2 13 (1): 22. Binder Stefanie, Zipfel Ivonne, Friedrich Maik, Riedel Diana, Ende Stefanie, Kämpf Christoph, Wiedemann Karolin, Buschmann Tilo, Puppel Sven-Holger, Reiche Kristin, Stadler Peter F, Horn Friedema |
IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification. Haematologica 2019 8 105 (5): 1391-1404. Teoh Phaik Ju, Chung Tae-Hoon, Chng Pamela Y Z, Toh Sabrina H M, Chng Wee J |
Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients. Blood cancer journal 2016 6 e397. Kortuem K M, Braggio E, Bruins L, Barrio S, Shi C S, Zhu Y X, Tibes R, Viswanatha D, Votruba P, Ahmann G, Fonseca R, Jedlowski P, Schlam I, Kumar S, Bergsagel P L, Stewart A |
The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. Cytokine 2013 Oct 64 (1): 422-6. Mazur Grzegorz, G?bura Katarzyna, Gieryng Anna, Butrym Aleksandra, Wróbel Tomasz, Bogunia-Kubik Katarzy |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: